$1.64 Billion Blow: J&J Unit Hit Hard in HIV Drug Marketing Showdown
A Johnson & Johnson division has been slammed with a $1.64 billion penalty in a courtroom saga that cast a harsh spotlight on the pharmaceutical giant’s marketing of two HIV medications. The ruling comes from a federal courtroom in Trenton, New Jersey, where U.S. District Judge Zahid Quraishi upheld a whistleblower suit that accused J&J’s …
$1.64 Billion Blow: J&J Unit Hit Hard in HIV Drug Marketing Showdown Read More »